A new antibody-drug, referred to as a Trojan horse, has been shown to reduce the risk of death by 42% in patients with Claudina 18.2 positive stomach cancer, with a 53% reduction in more advanced cases, according to a study presented at the congress of the European Society for Medical Oncology. #TumoreGastrico #OncologiaDiPrecisione #AnticorpoFarmaco (translated)
www.ilmessaggero.it
Tumore allo stomaco, arriva l'anticorpo-farmaco ?cavallo di Troia?: riduce il rischio di morte del 42%
